Thus, it is possible that TLR7 activation of B cells may occur through Ro and La-mediated activation of B cells in the context of human disease, although further studies are needed to identify clinically-relevant sources of TLR7 activation in pSS patients. This evidence concerns the gene TLR7 and peeling skin syndrome.